In ALL, the incidence of DIC is mainly correlated with the administration of asparaginase, as it disrupts the hepatic synthesis of antithrombin, fibrinogen, and other coagulation proteins, increasing the risk of both hemorrhagic and thrombotic events [75]. Here, ASPG is linked to acute lymphoblastic leukemia.